Idexx Laboratories, Inc. share price logo

Idexx Laboratories, Inc. Share Price

NASDAQ: IDXX

Large Cap

$579.96

+2.84

(+0.49%)

as on

Idexx Laboratories, Inc. Stock Performance

as on March 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $575.51
    $585.99
    downward going graph

    0.77%

    Downside

    1.04%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.42
    $1.56
    downward going graph

    99.76%

    Downside

    -99.73%

    Upside

    downward going graph

Idexx Laboratories, Inc. share price movements today

Previous Close
$577.12
Open
$577.02
Volume
250.0K
Day's Low - High
$575.51 - $585.99
52 Week Low - High
$1.42 - $1.56

Idexx Laboratories, Inc. Historical Returns

1 Month Return
-8.78 %
3 Month Return
-17.2 %
1 Year Return
+ 37.86 %
3 Year Return
+ 19.99 %
5 Year Return
+ 19.59 %

Idexx Laboratories, Inc. Stock Fundamentals & Key Indicators

Check Idexx Laboratories, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.1B

EPS (TTM)

14.5119

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.18%

PE Ratio (TTM)

44.05

Industry PE ratio

17.63179487179487

PEG Ratio

4.1136

EBITDA

1.5B

Revenue (TTM)

4.3B

Profit Margin

24.62%

Return On Equity TTM

66.20%

Idexx Laboratories, Inc. Stock Valuation

Track how Idexx Laboratories, Inc. P/E has moved over time to understand its valuation trends.

Idexx Laboratories, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (38.09x)

March 31, 2025

Industry (17.63x)

March 20, 2026

Today (44.05x)

March 20, 2026

Highest (79.24x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 44.05x

Idexx Laboratories, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Idexx Laboratories, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Idexx Laboratories, Inc. image
Idexx Laboratories, Inc.
BUY$46.1B19.59%44.0524.62%
Waters Corporation image
Waters Corporation
HOLD$29.4B11.49%27.8220.30%
Thermo Fisher Scientific, Inc. image
Thermo Fisher Scientific, Inc.
BUY$172.6B5.66%26.1815.05%
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$31.6B-8.92%24.6718.26%
Danaher Corp. image
Danaher Corp.
BUY$135.4B-14%3814.71%

Stock Returns calculator for Idexx Laboratories, Inc. Stock including INR - Dollar returns

The Idexx Laboratories, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Idexx Laboratories, Inc. investment value today

Current value as on today

₹1,45,844

Returns

₹45,844

(+45.84%)

Returns from Idexx Laboratories, Inc. Stock

₹37,882 (+37.88%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Idexx Laboratories, Inc. Stock

Based on 19 analysts

BUY

68.42%

Buy

31.58%

Hold

0.00%

Sell

Based on 19 analysts, 68.42% of analysts recommend a 'BUY' rating for Idexx Laboratories, Inc.. Average target price of $750.23

Idexx Laboratories, Inc. Share Price Target

Get share price movements and forecasts by analysts on Idexx Laboratories, Inc..

What analysts predicted

22.7%UPSIDE

Target Price

$750.23

Current Price

$579.96

Analyzed by

19 Analysts

Target

$750.23

Idexx Laboratories, Inc. target price $750.23, a slight upside of 22.7% compared to current price of $579.96. According to 19 analysts rating.

Idexx Laboratories, Inc. Stock’s Investor Sentiment and Interest

Search interest for Idexx Laboratories, Inc. Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-40% versus previous 30 day period

Idexx Laboratories, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
915
901
964
1,003
975
954
998
1,109
1,105
1,090
Gross Profit
547
526
593
620
596
570
623
694
683
658
Operating Income
275
245
298
263
303
261
316
373
354
315
EBITDA
305
278
334
300
341
298
351
409
392
356
Interest Expense
8
9
7
8
7
7
7
11
10
10
Depreciation
28
29
29
32
34
33
34
35
36
38
Income Before Tax
267
239
295
259
298
256
310
362
344
306
Income Tax Expense
55
45
59
55
66
40
67
68
70
58
Net Income
212
194
235
203
232
216
242
293
274
248
Net Profit Margin
23.18%
21.58%
24.44%
20.26%
23.87%
22.65%
24.31%
26.50%
24.85%
22.76%

Idexx Laboratories, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,775
1,969
2,213
2,406
2,706
3,215
3,367
3,660
3,897
4,303
Gross Profit
975
1,097
1,241
1,365
1,571
1,889
2,004
2,189
2,378
2,659
Operating Income
350
413
491
552
694
932
898
1,097
1,128
1,360
EBITDA
428
496
574
640
790
1,036
1,010
1,097
1,275
1,468
Interest Expense
28
31
33
30
32
29
38
35
31
38
Depreciation
-
83
83
88
95
104
111
113
129
145
Income Before Tax
321
381
457
522
661
902
859
1,061
1,109
1,324
Income Tax Expense
99
117
80
94
79
157
180
216
221
264
Net Income
222
263
377
427
581
744
679
845
887
1,059
Net Profit Margin
12.51%
13.36%
17.04%
17.77%
21.49%
23.17%
20.17%
23.08%
22.78%
24.62%

Idexx Laboratories, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
194
235
203
232
216
242
293
274
248
Operating Cash Flow
249
198
248
220
262
237
185
402
352
Investing Cash Flow
-30
-106
-32
-27
-39
-29
-33
-44
-28
Financing Cash Flow
-101
-144
-210
-290
-232
-330
-165
-313
-351
Change in Cash
122
-56
4
-92
-20
-124
0
43
-28

Idexx Laboratories, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
263
377
427
582
744
679
845
887
1,059
Operating Cash Flow
373
400
459
648
755
542
906
929
1,178
Investing Cash Flow
-138
138
-205
-109
-292
-195
-125
-207
-136
Financing Cash Flow
-208
-597
-286
-248
-697
-370
-441
-878
-1,161
Change in Cash
32
-63
-33
293
-239
-31
341
-165
-108

Mutual Funds that own Idexx Laboratories, Inc. Stock

Check out the Mutual Funds with significant holdings in Idexx Laboratories, Inc..

Global Institutional Holdings in Idexx Laboratories, Inc.

Funds
Holdings
Geode Capital Management, LLC
3.25%
Amundi
0.84%
Morgan Stanley - Brokerage Accounts
2.04%
Bank of New York Mellon Corp
2.58%
BAMCO Inc
2.26%
See all

Idexx Laboratories, Inc. News & Key Events

  • img

    Today's Timeline - 02 March

    Mon, 08:59 PM

    -

    IDEXX's innovation strategy drives double-digit growth in veterinary diagnostics and long-term revenue targets.

    Tue, 03:40 AM

    -

    IDEXX CEO Jonathan Jay Mazelsky sells 23,326 shares for approximately $15.34 million.

Insights on Idexx Laboratories, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IDXX stock has moved up by 37.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IDXX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IDXX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Idexx Laboratories, Inc. has experienced a decline in net profit over the last three quarters. The profit decreased from $293.98 million to $248.18 million, resulting in an average quarterly decrease of 8.1%.

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Idexx Laboratories, Inc. has experienced a decline in revenue for the last three quarters. The revenue decreased from $1.10 billion to $1.09 billion, averaging a decrease of 0.9% per quarter.

About Idexx Laboratories, Inc.

idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
OrganisationIdexx Laboratories, Inc.
HeadquartersOne IDEXX Drive, Westbrook, ME, United States, 04092
IndustryHealth Technology
CEOMr. Jonathan J. Mazelsky
E-voting on sharesClick here to vote

Key Management of Idexx Laboratories, Inc.

Name

Title

Mr. Bob Asmann

Senior Vice President of Global Operations

Dr. Nimrata Khatra Hunt P.E., Ph.D.

Executive Vice President of Global Strategy & Commercial

Dr. Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Mr. Andrew Emerson

Executive VP, CFO & Treasurer

Ms. Sharon E. Underberg J.D.

Executive VP, General Counsel, & Corporate Secretary

Ms. Julie Godon

Senior VP & Global Marketing Officer

Mr. Michael P. Johnson

Executive VP & Chief Human Resources Officer

Mr. Jonathan J. Mazelsky

President, CEO & Director

Mr. Michael J. Lane

Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology

Mr. Amit Gupta

Senior VP, Chief Digital & Information Officer

FAQs

What is Idexx Laboratories, Inc. share price today?

Idexx Laboratories, Inc. share price today is $579.96 as on at the close of the market. Idexx Laboratories, Inc. share today touched a day high of $585.99 and a low of $575.51.

What is the 52 week high and 52 week low for Idexx Laboratories, Inc. share?

Idexx Laboratories, Inc. share touched a 52 week high of $1.56 on and a 52 week low of $1.42 on . Idexx Laboratories, Inc. stock price today i.e. is closed at $579.96,which is -37076.92% down from its 52 week high and 40742.25% up from its 52 week low.

What is Idexx Laboratories, Inc.'s market capitalisation today?

Idexx Laboratories, Inc. market capitalisation is $0.05T as on .

How to invest in Idexx Laboratories, Inc. Stock (IDXX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Idexx Laboratories, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Idexx Laboratories, Inc. Shares that will get you 0.0026 shares as per Idexx Laboratories, Inc. share price of $579.96 per share as on March 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Idexx Laboratories, Inc. Stock (IDXX) from India?

Indian investors can start investing in Idexx Laboratories, Inc. (IDXX) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Idexx Laboratories, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Idexx Laboratories, Inc. share’s latest price of $579.96 as on March 20, 2026 at 1:29 am IST, you will get 0.0172 shares of Idexx Laboratories, Inc.. Learn more about fractional shares .

What are the returns that Idexx Laboratories, Inc. has given to Indian investors in the last 5 years?

Idexx Laboratories, Inc. stock has given 19.59% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?